SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Two Drugs Better Than One for High Blood Pressure
April 1, 2008
 · 
1 min read
Drug Development
ADHD Drugs Seen As Not Linked To Future Drug Abuse, New York University Study
April 1, 2008
 · 
1 min read
Drug Development
Eli Lilly and Company Drug Reduces Stent Clot Risks, Study Finds
March 31, 2008
 · 
1 min read
Drug Development
Angiomax Works Just As Well As Heparin
March 31, 2008
 · 
1 min read
Drug Development
New Schizophrenia Drugs No Better, Dutch Team Find
March 28, 2008
 · 
1 min read
Drug Development
Two Cholesterol Drugs Better Than One For Diabetics, American Journal of Cardiology
March 25, 2008
 · 
1 min read
Drug Development
Roche Holding AG’s Xenical Helps Lower Blood Pressure, Abbott Laboratories’ Appetite Suppressant Meridia Did Not
March 25, 2008
 · 
1 min read
Drug Development
TB Drug Treatment Fluoroquinones Can Lead to Severe Pneumonia, National Institute for Communicable Diseases Study
March 24, 2008
 · 
1 min read
Drug Development
Prenatal Acetaminophen: An Asthma Link?
March 20, 2008
 · 
1 min read
Drug Development
Long-Term Use of Osteoporosis Drug Fosamax May Weaken Long Bones, Weill Medical College of Cornell University Study
March 20, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Little Addicts? Purdue Pharma L.P. to Test OxyContin on Kids
July 3, 2012
 · 
1 min read
Drug Development
Orexo AB Takes Large Step Forward on the Road to Improve Treatment for People Dependent on Opioid Pain Killers
July 2, 2012
 · 
1 min read
Drug Development
Onyx Pharmaceuticals, Inc. Initiates Phase 3 Kyprolis™ Head-to-Head Comparison Trial vs. Velcade® in Patients With Relapsed Multiple Myeloma
July 2, 2012
 · 
5 min read
Drug Development
Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
June 28, 2012
 · 
9 min read
Drug Development
Merck & Co., Inc. Release: Patients with Type 2 Diabetes Fasting for Ramadan in India and Malaysia Were About Half as Likely to Experience Low Blood Sugar When Switched from a Sulfonylurea to MSD’s JANUVIA® (sitagliptin)
June 28, 2012
 · 
1 min read
Drug Development
Vertex Pharmaceuticals Incorporated Offers More Evidence for Cystic Fibrosis Drug
June 28, 2012
 · 
14 min read
Drug Development
CSL Behring Release: PRIMA Study Shows Treatment with Privigen® Improved Function in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
June 27, 2012
 · 
5 min read
Drug Development
Access Pharmaceuticals to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
June 27, 2012
 · 
3 min read
Drug Development
Boehringer Ingelheim Corporation Release: No Significant Difference in the Risk of Acute Coronary Syndrome (including Myocardial Infarction) Seen With Pradaxa®(dabigatran etexilate) Compared to Enoxaparin for VTE Prevention After Orthopaedic Surgery
June 25, 2012
 · 
1 min read
Drug Development
FDA: Amylin Pharmaceuticals, Inc. Concealed Heart Safety Risks of Key Diabetes Drug
June 25, 2012
 · 
1 min read
Drug Development
Genentech Says Perjeta Combination Increased Survival in Breast Cancer Patients
June 22, 2012
 · 
10 min read
Drug Development
Boehringer Ingelheim Corporation Release: First Study to Evaluate Alternative to Warfarin for Mechanical Heart Valve Patients Launched with Pradaxa® (dabigatran etexilate)
June 20, 2012
 · 
1 min read
Drug Development
Bristol-Myers Squibb Company Hep. C Trial Change Has Big Implications
June 20, 2012
 · 
1 min read
Drug Development
Pfizer Inc.: Xalkori Improves Lung Cancer Patients’ Survival in Phase III Trial
June 19, 2012
 · 
10 min read
Drug Development
Spectrum Pharmaceuticals, Inc. Announces Outstanding ZEVALIN® Clinical Data In Aggressive Relapsed/Refractory Lymphoma; Presented at the 17th Congress of the European Hematology Association
June 18, 2012
 · 
1 min read
Drug Development
Boehringer Ingelheim GmbH Release: AF Patients Who Require Surgery Benefit From a Shorter Treatment Interruption on Dabigatran Etexilate (Pradaxa®) Compared to Warfarin
June 18, 2012
 · 
1 min read
Drug Development
FDA Staff Question Value of Sanofi (France) Blood Clot Drug
June 18, 2012
 · 
1 min read
Drug Development
FDA Focuses on Toxic Side Effects With Onyx Pharmaceuticals, Inc. Drug
June 18, 2012
 · 
1 min read
Drug Development
Sanofi (France) Announces Results of ORIGIN, the World’s Longest and Largest Randomised Clinical Trial in Insulin in Pre- and Early Diabetes
June 15, 2012
 · 
1 min read
Drug Development
Alkermes plc Release: INVEGA® SUSTENNA® Three-Month Formulation of Paliperidone Palmitate Enters Phase 3 Clinical Program for Schizophrenia
June 12, 2012
 · 
1 min read
Load More